Julien Boudon

Dr. Julien Boudon

Université de Bourgogne, Dijon, Bourgogne-Franche-Comté, France
+1
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2011 in Analytical Chemistry
Verified
Journal Article
Closed access
SKStefan Knoppe
Stefan Knoppe
JBJulien Boudon
Julien Boudon
IDIgor Dolamic
Igor Dolamic
ADAmala Dass
Amala Dass
TBThomas Bürgi
Thomas Bürgi

13 January 2021 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
NSNimisha Singh
Nimisha Singh
CMCélia Marets
Célia Marets
JBJulien Boudon
Julien Boudon
Nadine MillotNadine Millot
Nadine Millot
LSLucien Saviot
Lucien Saviot
Lionel MauriziLionel Maurizi
Lionel Maurizi
Nanomaterials have a huge potential in research fields from nanomedicine to medical devices. However, surface modifications of nanoparticles (NPs) and thus of their physicochemical properties failed to predict their biological behavior. This requires investigating the “missing link” at the nano-bio interface. The protein corona (PC), the set of proteins binding to the NPs surface, plays a critical role in particle recognition by the innate immune system. Still, in vitro incubation offers a limited understanding of biological interactions and fails to explain the in vivo fate. To date, several reports explained the impact of PC in vitro but its applications in the clinical field have been very limited. Furthermore, PC is often considered as a biological barrier reducing the targeting efficiency of nano vehicles. But the protein binding can actually be controlled by altering PC both in vitro and in vivo. Analyzing PC in vivo could accordingly provide a deep understanding of its biological effect and speed up the transfer to clinical applications. This review demonstrates the need for clarifications on the effect of PC in vivo and the control of its behavior by changing its physicochemical properties. It unfolds the recent in vivo developments to understand mechanisms and challenges at the nano-bio interface. Finally, it reports recent advances in the in vivo PC to overcome and control the limitations of the in vitro PC by employing PC as a boosting resource to prolong the NPs half-life, to improve their formulations and thereby to increase its use for biomedical applications.

4 August 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JMJérémie Mitteaux
Jérémie Mitteaux
PLPauline Lejault
Pauline Lejault
FWFilip Wojciechowski
Filip Wojciechowski
AJAlexandra Joubert
Alexandra Joubert
JBJulien Boudon
Julien Boudon
DMDavid Monchaud
David Monchaud

2 July 2009 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
SSSatyabrata Si
Satyabrata Si
CGCyrille Gautier
Cyrille Gautier
JBJulien Boudon
Julien Boudon
RTRossana Taras
Rossana Taras
SGSerafino Gladiali
Serafino Gladiali
TBThomas Bürgi
Thomas Bürgi

10 February 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Amira MAHMOUDAmira MAHMOUD
Amira MAHMOUD
MEMosaab Echabaane
Mosaab Echabaane
KOKarim omri
Karim omri
JBJulien Boudon
Julien Boudon
LSLucien Saviot
Lucien Saviot
RCRafik Ben Chaabane
Rafik Ben Chaabane
Copper-doped zinc oxide nanoparticles (NPs) CuxZn1−xO (x = 0, 0.01, 0.02, 0.03, and 0.04) were synthesized via a sol-gel process and used as an active electrode material to fabricate a non-enzymatic electrochemical sensor for the detection of glucose. Their structure, composition, and chemical properties were characterized using X-ray diffraction (XRD), transmission electron microscopy (TEM), Fourier-transform infrared (FTIR) and Raman spectroscopies, and zeta potential measurements. The electrochemical characterization of the sensors was studied using cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and differential pulse voltammetry (DPV). Cu doping was shown to improve the electrocatalytic activity for the oxidation of glucose, which resulted from the accelerated electron transfer and greatly improved electrochemical conductivity. The experimental conditions for the detection of glucose were optimized: a linear dependence between the glucose concentration and current intensity was established in the range from 1 nM to 100 μM with a limit of detection of 0.7 nM. The proposed sensor exhibited high selectivity for glucose in the presence of various interfering species. The developed sensor was also successfully tested for the detection of glucose in human serum samples.

1 May 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
MJMarie-Josée Jacobin-Valat
Marie-Josée Jacobin-Valat
JLJeanny Laroche-Traineau
Jeanny Laroche-Traineau
MLMélusine Larivière
Mélusine Larivière
SMStéphane Mornet
Stéphane Mornet
SSStéphane Sanchez
Stéphane Sanchez
GCGisèle Clofent-Sanchez
Gisèle Clofent-Sanchez